Paperpal Prime Logo

Alzheimer's Research and Therapy : Impact Factor & More

eISSN: 1758-9193pISSN: 1758-9193
JournalOpen Access

Key Metrics

CiteScore
9
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.89 5-Year SI
SJR
Q1Neurology
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Alzheimer's Research and Therapy

Alzheimer's Research and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Springer Nature
Language English
Frequency Continuous publication
Article Processing ChargesGBP 2390 | USD 3590
Publication Time16
Editorial Review ProcessPeer review
General Details
LanguageEnglish
Society/Institute/SponsorAlzheimer's Disease International
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Alzheimer's Research and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Alzheimer's Research and Therapy

Semantic fluency predicts survival of memory clinic patients.
  • 7 Aug 2026
  • Alzheimer's research & therapy
SuperAging is not the inverse of common-variant Alzheimer\u2019s risk: evidence across genetic ancestries
  • 23 Jul 2026
  • Alzheimer's Research & Therapy
Personalized non-invasive combined magnetic and electrical stimulation of the default mode network in mild AD patients (CMES-AD): a multicentric randomized sham-controlled trial protocol.
  • 21 Jul 2026
  • Alzheimer's research & therapy
Resting-state functional dynamics alterations relate to plasma amyloid markers and statistically explain memory impairments in the TgF344-AD model of Alzheimer's disease.
  • 17 Jul 2026
  • Alzheimer's research & therapy
Blood-based immunophenotyping of T cell profiles in patients with neurodegenerative disorders.
  • 16 Jul 2026
  • Alzheimer's research & therapy
Sequential associations of myelin dysfunction with Aβ and Tau pathology in Alzheimer's disease: a dynamic myelin perturbation.
  • 15 Jul 2026
  • Alzheimer's research & therapy
Semantic fluency predicts survival of memory clinic patients.
  • 7 Aug 2026
  • Alzheimer's research & therapy
SuperAging is not the inverse of common-variant Alzheimer\u2019s risk: evidence across genetic ancestries
  • 23 Jul 2026
  • Alzheimer's Research & Therapy
Personalized non-invasive combined magnetic and electrical stimulation of the default mode network in mild AD patients (CMES-AD): a multicentric randomized sham-controlled trial protocol.
  • 21 Jul 2026
  • Alzheimer's research & therapy
Resting-state functional dynamics alterations relate to plasma amyloid markers and statistically explain memory impairments in the TgF344-AD model of Alzheimer's disease.
  • 17 Jul 2026
  • Alzheimer's research & therapy
Blood-based immunophenotyping of T cell profiles in patients with neurodegenerative disorders.
  • 16 Jul 2026
  • Alzheimer's research & therapy
Sequential associations of myelin dysfunction with Aβ and Tau pathology in Alzheimer's disease: a dynamic myelin perturbation.
  • 15 Jul 2026
  • Alzheimer's research & therapy

FAQs on Alzheimer's Research and Therapy